TP53 and urogenital neoplasm: Moreover, we found some reports that supported our findings of the response to chemotherapy, such as reports of TP53 mutation as a marker of chemotherapy response in breast cancer31and bladder cancer74, and as a marker of resistance to chemotherapy in head and neck cancer32,75.